Topera Takes $25M More For Medical 3D Analysis System

In a bid to help bring its products to market, San Diego-based Topera Medical said Thursday that it has raised $25M in a Series C financing, which will go towards its 3D analysis and mapping system for treating atrial fibrillation. The new funding was led by new enterprise Associates, and also included the firm's existing investors, a new, un-named strategic partner, and the firm's management team. The company said the new funds go towards a planned, 2013 commercial launch of its products in both the U.S. and europe. NEA's Justin Klein joins the company's board. Topera's medical device is used to map and image the electrical signals in the human heart, in order to detect the electrical source of complex cardiac arrhythmias, so that they can be treated better. More information »